,38 These findings, supported by both previous studies and our data from clinical cohorts and in vitro experiments, suggest that dysregulation of the RB1/E2F1 axis in advanced prostate cancer may drive lethal disease progression by regulating CDRs. This evidence concerns the gene RB1 and prostate cancer.